Compared with patients with resting cardiac power/mass ≥ 0.7 W/m2, those with resting cardiac power/mass < 0.7 W/m2 were older, had higher NT-proBNP, more comorbidities and larger percentage of NYHA class IV, ischemic heart disease and atrial fibrillation, used more cardiovascular medications, while had lower eGFR. Here, NPPB is linked to coronary artery disorder.